Poster
# 65

Main Page

6th Internet World Congress for Biomedical Sciences

IndexIndex
One-page version
Dynamic pages

Determination of the Protection Level for Post Chemotherapy Emesis with a Multilayer Perceptron.

Antonio J. Serrano López(1), Gustavo Camps i Valls(2), EMILIO SORIA OLIVAS(3), NICOLÁS VICTOR JIMÉNEZ TORRÉS(4), José David Martín Guerrero(5), Jose Ramon Sepulveda Sanchis(6)
(1)(6)Dpto. Electrónica. Universidad de Valencia - Burjasot. Spain
(2)Universitat de València - Burjassot, Valencia. Spain
(3)DPTO INGENIERÍA ELECTRONICA. FACULTAD DE FISICAS - BURJASSOT/VALENCIA. Spain
(4)DPTO FARMACIA Y TECNOLOGÍA FARMACEÚTICA. FACULTAD DE FARMACIA - BURJASSOT/VALENCIA. Spain
(5)G.P.D.S. Departament d´Enginyeria Electrònica. Universitat de València - Burjassot. Spain

[ABSTRACT] [INTRODUCTION] [DEVELOPMENT] [RESULTS] [IMAGES] [CONCLUSIONS] [BIBLIOGRAPHY] [Discussion Board]
IMAGES Previous: DIFFERENT ANXIOLYTIC EFFECTS OF DIAZEPAM IN FISCHER 344 RATS AND TWO STOCKS OF WISTAR RATS IN THE ELEVATED PLUS MAZE Previous: NEMESIS: A new telemedicine approach for co-operative work on cardiology Previous: Analysis Of The Results Of Surgical Treatment For Squamous Cell Carcinoma Of Mobile Tongue And Base Of Tongue BIBLIOGRAPHY
[Pharmacology]
Next: GENTAMICIN CONTAINING SURGICAL BONE CEMENT: 
IN VITRO ELUTION CHARACTERISTICS OF PALACOS® AND PALAMED®
[Health Informatics]
Next: Decision Making Aid for Digoxin Administration with Neural Networks
[Oncology]
Next: Analysis of the outcome of the surgical treatment for squamous cell carcinoma of the oral cavity and oropharynx.

CONCLUSIONS

Classification according to emesis level is a very difficult task. This is caused by the great number of physiological influences and the fact that patients are not always classified in their right group.

In spite of all troubles, a model based in neural network has been obtained that distinguishes the most problematic patients in the right way and maintains an appropriate behavior for the less problematic groups.

In the future, this model could be used as a tool to help medical personal to take decisions. This will improve control over adverse effects of chemoterapy, improving the live quality of oncologic patients.


Discussion Board
Discussion Board

Any Comment to this presentation?

[ABSTRACT] [INTRODUCTION] [DEVELOPMENT] [RESULTS] [IMAGES] [CONCLUSIONS] [BIBLIOGRAPHY] [Discussion Board]

IMAGES Previous: DIFFERENT ANXIOLYTIC EFFECTS OF DIAZEPAM IN FISCHER 344 RATS AND TWO STOCKS OF WISTAR RATS IN THE ELEVATED PLUS MAZE Previous: NEMESIS: A new telemedicine approach for co-operative work on cardiology Previous: Analysis Of The Results Of Surgical Treatment For Squamous Cell Carcinoma Of Mobile Tongue And Base Of Tongue BIBLIOGRAPHY
[Pharmacology]
Next: GENTAMICIN CONTAINING SURGICAL BONE CEMENT: 
IN VITRO ELUTION CHARACTERISTICS OF PALACOS® AND PALAMED®
[Health Informatics]
Next: Decision Making Aid for Digoxin Administration with Neural Networks
[Oncology]
Next: Analysis of the outcome of the surgical treatment for squamous cell carcinoma of the oral cavity and oropharynx.
Antonio J. Serrano López, Gustavo Camps i Valls, EMILIO SORIA OLIVAS, NICOLÁS VICTOR JIMÉNEZ TORRÉS, José David Martín Guerrero, Jose Ramon Sepulveda Sanchis
Copyright © 1999-2000. All rights reserved.
Last update: 15/01/00